US Stock MarketDetailed Quotes

Trevi Therapeutics (TRVI)

Watchlist
  • 15.270
  • +0.510+3.46%
Close May 13 16:00 ET
  • 15.120
  • -0.150-0.98%
Pre 04:06 ET
2.17BMarket Cap-47.72P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Trevi Therapeutics (TRVI) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
30.01%14.91M
-4.26%49.33M
-16.52%10.22M
-1.21%13.92M
3.26%13.72M
-3.66%11.47M
51.89%51.52M
37.05%12.24M
55.74%14.09M
58.54%13.29M
Selling and administrative expenses
35.86%4.97M
30.48%15.85M
38.15%4.03M
33.81%3.83M
32.59%4.33M
17.96%3.66M
18.62%12.15M
20.70%2.92M
5.18%2.86M
28.66%3.27M
-General and administrative expense
35.86%4.97M
30.48%15.85M
38.15%4.03M
33.81%3.83M
32.59%4.33M
17.96%3.66M
18.62%12.15M
20.70%2.92M
5.18%2.86M
28.66%3.27M
Research and development costs
27.27%9.94M
-14.98%33.48M
-33.61%6.19M
-10.15%10.09M
-6.31%9.39M
-11.28%7.81M
66.27%39.38M
43.11%9.33M
77.51%11.22M
71.53%10.02M
Operating profit
-30.01%-14.91M
4.26%-49.33M
16.52%-10.22M
1.21%-13.92M
-3.26%-13.72M
3.66%-11.47M
-51.89%-51.52M
-37.05%-12.24M
-55.74%-14.09M
-58.54%-13.29M
Net non-operating interest income expense
50.76%1.7M
81.66%6.54M
126.01%1.9M
154.67%2.1M
50.64%1.41M
12.84%1.13M
-17.42%3.6M
-25.68%842K
-30.08%825K
-11.39%934K
Non-operating interest income
50.76%1.7M
81.45%6.54M
125.74%1.9M
154.36%2.1M
50.48%1.41M
12.73%1.13M
-24.14%3.6M
-25.86%843K
-30.18%826K
-22.54%935K
Non-operating interest expense
----
--0
--0
--0
--0
--0
-98.98%4K
-75.00%1K
-66.67%1K
-99.35%1K
Other net income (expense)
166.67%4K
-106.67%-31K
-850.00%-15K
81.82%-2K
-40.00%-7K
-500.00%-6K
-103.20%-15K
166.67%2K
-107.14%-11K
-103.27%-5K
Other non- operating income (expenses)
166.67%4K
-106.67%-31K
-850.00%-15K
81.82%-2K
-40.00%-7K
-500.00%-6K
-103.20%-15K
166.67%2K
-107.14%-11K
-103.27%-5K
Income before tax
-27.64%-13.21M
10.68%-42.82M
26.91%-8.33M
10.97%-11.82M
0.31%-12.32M
5.12%-10.35M
-64.76%-47.94M
-46.08%-11.4M
-72.13%-13.27M
-72.26%-12.36M
Income tax
-81.82%-20K
-113.33%-64K
-200.00%-16K
51.61%-15K
-162.50%-21K
-37.50%-11K
6.25%-30K
-11.11%16K
-138.46%-31K
73.33%-8K
Net income
-27.58%-13.19M
10.75%-42.76M
27.15%-8.32M
10.87%-11.8M
0.41%-12.3M
5.16%-10.34M
-64.84%-47.91M
-45.95%-11.42M
-72.02%-13.24M
-72.88%-12.35M
Net income continuous Operations
-27.58%-13.19M
10.75%-42.76M
27.15%-8.32M
10.87%-11.8M
0.41%-12.3M
5.16%-10.34M
-64.84%-47.91M
-45.95%-11.42M
-72.02%-13.24M
-72.88%-12.35M
Minority interest income
Net income attributable to the parent company
-27.58%-13.19M
10.75%-42.76M
27.15%-8.32M
10.87%-11.8M
0.41%-12.3M
5.16%-10.34M
-64.84%-47.91M
-45.95%-11.42M
-72.02%-13.24M
-72.88%-12.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-27.58%-13.19M
10.75%-42.76M
27.15%-8.32M
10.87%-11.8M
0.41%-12.3M
5.16%-10.34M
-64.84%-47.91M
-45.95%-11.42M
-72.02%-13.24M
-72.88%-12.35M
Basic earnings per share
0.00%-0.09
31.91%-0.32
45.45%-0.06
38.46%-0.08
25.00%-0.09
18.18%-0.09
-62.07%-0.47
-37.50%-0.11
-62.50%-0.13
-71.43%-0.12
Diluted earnings per share
0.00%-0.09
31.91%-0.32
45.45%-0.06
38.46%-0.08
25.00%-0.09
18.18%-0.09
-62.07%-0.47
-37.50%-0.11
-62.50%-0.13
-71.43%-0.12
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 30.01%14.91M-4.26%49.33M-16.52%10.22M-1.21%13.92M3.26%13.72M-3.66%11.47M51.89%51.52M37.05%12.24M55.74%14.09M58.54%13.29M
Selling and administrative expenses 35.86%4.97M30.48%15.85M38.15%4.03M33.81%3.83M32.59%4.33M17.96%3.66M18.62%12.15M20.70%2.92M5.18%2.86M28.66%3.27M
-General and administrative expense 35.86%4.97M30.48%15.85M38.15%4.03M33.81%3.83M32.59%4.33M17.96%3.66M18.62%12.15M20.70%2.92M5.18%2.86M28.66%3.27M
Research and development costs 27.27%9.94M-14.98%33.48M-33.61%6.19M-10.15%10.09M-6.31%9.39M-11.28%7.81M66.27%39.38M43.11%9.33M77.51%11.22M71.53%10.02M
Operating profit -30.01%-14.91M4.26%-49.33M16.52%-10.22M1.21%-13.92M-3.26%-13.72M3.66%-11.47M-51.89%-51.52M-37.05%-12.24M-55.74%-14.09M-58.54%-13.29M
Net non-operating interest income expense 50.76%1.7M81.66%6.54M126.01%1.9M154.67%2.1M50.64%1.41M12.84%1.13M-17.42%3.6M-25.68%842K-30.08%825K-11.39%934K
Non-operating interest income 50.76%1.7M81.45%6.54M125.74%1.9M154.36%2.1M50.48%1.41M12.73%1.13M-24.14%3.6M-25.86%843K-30.18%826K-22.54%935K
Non-operating interest expense ------0--0--0--0--0-98.98%4K-75.00%1K-66.67%1K-99.35%1K
Other net income (expense) 166.67%4K-106.67%-31K-850.00%-15K81.82%-2K-40.00%-7K-500.00%-6K-103.20%-15K166.67%2K-107.14%-11K-103.27%-5K
Other non- operating income (expenses) 166.67%4K-106.67%-31K-850.00%-15K81.82%-2K-40.00%-7K-500.00%-6K-103.20%-15K166.67%2K-107.14%-11K-103.27%-5K
Income before tax -27.64%-13.21M10.68%-42.82M26.91%-8.33M10.97%-11.82M0.31%-12.32M5.12%-10.35M-64.76%-47.94M-46.08%-11.4M-72.13%-13.27M-72.26%-12.36M
Income tax -81.82%-20K-113.33%-64K-200.00%-16K51.61%-15K-162.50%-21K-37.50%-11K6.25%-30K-11.11%16K-138.46%-31K73.33%-8K
Net income -27.58%-13.19M10.75%-42.76M27.15%-8.32M10.87%-11.8M0.41%-12.3M5.16%-10.34M-64.84%-47.91M-45.95%-11.42M-72.02%-13.24M-72.88%-12.35M
Net income continuous Operations -27.58%-13.19M10.75%-42.76M27.15%-8.32M10.87%-11.8M0.41%-12.3M5.16%-10.34M-64.84%-47.91M-45.95%-11.42M-72.02%-13.24M-72.88%-12.35M
Minority interest income
Net income attributable to the parent company -27.58%-13.19M10.75%-42.76M27.15%-8.32M10.87%-11.8M0.41%-12.3M5.16%-10.34M-64.84%-47.91M-45.95%-11.42M-72.02%-13.24M-72.88%-12.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -27.58%-13.19M10.75%-42.76M27.15%-8.32M10.87%-11.8M0.41%-12.3M5.16%-10.34M-64.84%-47.91M-45.95%-11.42M-72.02%-13.24M-72.88%-12.35M
Basic earnings per share 0.00%-0.0931.91%-0.3245.45%-0.0638.46%-0.0825.00%-0.0918.18%-0.09-62.07%-0.47-37.50%-0.11-62.50%-0.13-71.43%-0.12
Diluted earnings per share 0.00%-0.0931.91%-0.3245.45%-0.0638.46%-0.0825.00%-0.0918.18%-0.09-62.07%-0.47-37.50%-0.11-62.50%-0.13-71.43%-0.12
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +21.52%
Sample Name
Sample Code
 +18.03%
Sample Name
Sample Code
 +17.02%
4
United States Oil Fund LP
USO
+15.87%
5
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+11.63%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.98%
Sample Name
Sample Code
 +10.85%
Sample Name
Sample Code
 +10.04%
4
Kingsoft Cloud
KC
+7.76%
5
Hesai
HSAI
+7.08%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -